127 related articles for article (PubMed ID: 31046610)
21. [Relation of the histological picture of biopsy material and prognosis in cases of squamous cell carcinoma of the oral cavity].
Suba Z; Szabó G; Tóth-Bagi Z
Fogorv Sz; 1993 Sep; 86(9):297-303. PubMed ID: 8243745
[TBL] [Abstract][Full Text] [Related]
22. Prolonged antiretroviral therapy is associated with fewer anal high-grade squamous intraepithelial lesions in HIV-positive MSM in a cross-sectional study.
Libois A; Feoli F; Nkuize M; Delforge M; Konopnicki D; Clumeck N; De Wit S
Sex Transm Infect; 2017 Feb; 93(1):15-17. PubMed ID: 27030607
[TBL] [Abstract][Full Text] [Related]
23. HIV-associated psoriasis: Epidemiology, pathogenesis, and management.
Ceccarelli M; Venanzi Rullo E; Vaccaro M; Facciolà A; d'Aleo F; Paolucci IA; Cannavò SP; Cacopardo B; Pinzone MR; Pellicanò GF; Condorelli F; Nunnari G; Guarneri C
Dermatol Ther; 2019 Mar; 32(2):e12806. PubMed ID: 30588732
[TBL] [Abstract][Full Text] [Related]
24. Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy.
Stadler RF; Gregorcyk SG; Euhus DM; Place RJ; Huber PJ; Simmang CL
Dis Colon Rectum; 2004 Aug; 47(8):1305-9. PubMed ID: 15484343
[TBL] [Abstract][Full Text] [Related]
25. Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.
AbdulMajeed AA; Dalley AJ; Farah CS
Ann Diagn Pathol; 2013 Aug; 17(4):331-40. PubMed ID: 23643910
[TBL] [Abstract][Full Text] [Related]
26. HIV patients are at higher risk for developing oral malignancies.
Yenuganti J
HIV Clin; 2008; 20(2):7-9. PubMed ID: 18661633
[No Abstract] [Full Text] [Related]
27. An overview of epidemiology and common risk factors for oral squamous cell carcinoma.
McDowell JD
Otolaryngol Clin North Am; 2006 Apr; 39(2):277-94. PubMed ID: 16580911
[TBL] [Abstract][Full Text] [Related]
28. Essentials of oral cancer.
Rivera C
Int J Clin Exp Pathol; 2015; 8(9):11884-94. PubMed ID: 26617944
[TBL] [Abstract][Full Text] [Related]
29. The pharmacokinetics of high-dose methotrexate in people living with HIV on antiretroviral therapy.
Dalla Pria A; Bendle M; Ramaswami R; Boffito M; Bower M
Cancer Chemother Pharmacol; 2016 Mar; 77(3):653-7. PubMed ID: 26696583
[TBL] [Abstract][Full Text] [Related]
30. Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation.
Grulich AE
Curr Opin HIV AIDS; 2009 May; 4(3):183-7. PubMed ID: 19532048
[TBL] [Abstract][Full Text] [Related]
31. A new classification for potentially malignant disorders of the oral cavity.
Sarode SC; Sarode GS; Karmarkar S; Tupkari JV
Oral Oncol; 2011 Sep; 47(9):920-1. PubMed ID: 21715215
[No Abstract] [Full Text] [Related]
32. Expression of Epstein-Barr virus among oral potentially malignant disorders and oral squamous cell carcinomas in the South Indian tobacco-chewing population.
Reddy SS; Sharma S; Mysorekar V
J Oral Pathol Med; 2017 Jul; 46(6):454-459. PubMed ID: 27704636
[TBL] [Abstract][Full Text] [Related]
33. [Detection of potentially malignant and malignant lesions of oral cavity using autofluorescence visualization device].
Matsumoto K
Kokubyo Gakkai Zasshi; 2011 Jun; 78(2):73-80. PubMed ID: 21827020
[TBL] [Abstract][Full Text] [Related]
34. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
[TBL] [Abstract][Full Text] [Related]
35. Relative Frequency of Oral Malignancies and Oral Precancer in the Biopsy Service of Jazan Province, 2009-2014.
Idris A; Vani N; Saleh S; Tubaigy F; Alharbi F; Sharwani A; Tadrus N; Warnakulasuriya S
Asian Pac J Cancer Prev; 2016; 17(2):519-25. PubMed ID: 26925637
[TBL] [Abstract][Full Text] [Related]
36. Complementary and Alternative Medicine Among Persons living with HIV in the Era of Combined Antiretroviral Treatment.
Halpin SN; Carruth EC; Rai RP; Edelman EJ; Fiellin DA; Gibert C; Gordon KS; Huang W; Justice A; Marconi VC; Rimland D; Perkins MM
AIDS Behav; 2018 Mar; 22(3):848-852. PubMed ID: 28733920
[TBL] [Abstract][Full Text] [Related]
37. A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse.
Kuchinad KE; Hutton HE; Monroe AK; Anderson G; Moore RD; Chander G
BMC Res Notes; 2016 Apr; 9():229. PubMed ID: 27103162
[TBL] [Abstract][Full Text] [Related]
38. Programmable bio-nanochip-based cytologic testing of oral potentially malignant disorders in Fanconi anemia.
Floriano PN; Abram T; Taylor L; Le C; Talavera H; Nguyen M; Raja R; Gillenwater A; McDevitt J; Vigneswaran N
Oral Dis; 2015 Jul; 21(5):593-601. PubMed ID: 25662766
[TBL] [Abstract][Full Text] [Related]
39. Clinical impact of iodine staining for diagnosis of carcinoma in situ in the floor of mouth, and decision of adequate surgical margin.
Watanabe A; Taniguchi M; Tsujie H; Hosokawa M; Fujita M; Sasaki S
Auris Nasus Larynx; 2012 Apr; 39(2):193-7. PubMed ID: 21885222
[TBL] [Abstract][Full Text] [Related]
40. Tumour budding evaluated in biopsy specimens is a useful predictor of prognosis in patients with cN0 early stage oral squamous cell carcinoma.
Seki M; Sano T; Yokoo S; Oyama T
Histopathology; 2017 May; 70(6):869-879. PubMed ID: 27926795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
